+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type, By Product Type, By Sample, By End-use, By Test Type, (Bioburden Testing, Sterility Testing, and Bacterial Endotoxin Testing). By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 143 Pages
  • March 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953687
The Europe Pharmaceutical Sterility Testing Market would witness market growth of 10.3% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Pharmaceutical Sterility Testing Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $171.5 Million by 2030. The UK market is exhibiting a CAGR of 9.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 11.2% during (2023 - 2030).



There is a growing interest in rapid sterility testing methods that offer quicker results compared to traditional culture-based methods. These methods leverage advanced technologies such as nucleic acid amplification and automated detection systems to expedite testing without compromising accuracy. With the increasing complexity of sterility testing and the need for specialized expertise, pharmaceutical companies are increasingly outsourcing these services to contract testing laboratories. This trend allows companies to access state-of-the-art facilities and skilled personnel without significant in-house investments.

Moreover, the pharmaceutical industry is embracing advanced technologies, including robotics, artificial intelligence, and machine learning, to enhance the efficiency and accuracy of sterility testing. Automated systems and data analytics contribute to rapidly and reliably detecting microbial contaminants. AI is employed to enhance the analytical capabilities of sterility testing. One notable application is in image recognition and analysis. AI algorithms can analyze microscopic images of culture media to detect microbial growth accurately. This expedites the identification process and increases the sensitivity and specificity of detection, reducing the likelihood of false positives or negatives. AI-driven systems can continuously learn and adapt, improving performance and staying abreast of evolving microbial strains.

Belgium is recognized as a European pharmaceutical industry hub, hosting numerous pharmaceutical companies, including multinational corporations and innovative biotech firms. The presence of these companies fuels the demand for sterility testing services to ensure compliance with regulatory standards. As per the data from the International Trade Administration, Belgium’s pharmaceutical industry spends $1.64 billion (€1.5 billion) on R&D every year, which is equivalent to 40 percent of all private investment made in Belgium. Therefore, the growing pharmaceutical sector in Europe will lead to enhanced growth in the regional pharmaceutical sterility testing market.

Based on Type, the market is segmented into Outsourcing, and In-House. Based on Product Type, the market is segmented into Kits & Reagents, Instruments, and Services. Based on Sample, the market is segmented into Pharmaceuticals, Medical Devices, and Biopharmaceuticals. Based on End-use, the market is segmented into Pharmaceutical Companies, Medical Device Companies, Compounding Pharmacies, and Others. Based on Test Type, the market is segmented into Bioburden Testing, Sterility Testing, and Bacterial Endotoxin Testing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Steris PLC
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Sartorius AG
  • Sotera Health Company
  • Pacific Biolabs, Inc.
  • Laboratory Corporation of America Holdings
  • Almac Group
  • Pace Analytical Services, LLC

Market Report Segmentation

By Type
  • Outsourcing
  • In-House
By Product Type
  • Kits & Reagents
  • Instruments
  • Services
By Sample
  • Pharmaceuticals
  • Medical Devices
  • Biopharmaceuticals
By End Use
  • Pharmaceutical Companies
  • Medical Device Companies
  • Compounding Pharmacies
  • Others
By Test Type
  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pharmaceutical Sterility Testing Market, by Type
1.4.2 Europe Pharmaceutical Sterility Testing Market, by Product Type
1.4.3 Europe Pharmaceutical Sterility Testing Market, by Sample
1.4.4 Europe Pharmaceutical Sterility Testing Market, by End Use
1.4.5 Europe Pharmaceutical Sterility Testing Market, by Test Type
1.4.6 Europe Pharmaceutical Sterility Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Pharmaceutical Sterility Testing Market by Type
4.1 Europe Outsourcing Market by Country
4.2 Europe In-House Market by Country
Chapter 5. Europe Pharmaceutical Sterility Testing Market by Product Type
5.1 Europe Kits & Reagents Market by Country
5.2 Europe Instruments Market by Country
5.3 Europe Services Market by Country
Chapter 6. Europe Pharmaceutical Sterility Testing Market by Sample
6.1 Europe Pharmaceuticals Market by Country
6.2 Europe Medical Devices Market by Country
6.3 Europe Biopharmaceuticals Market by Country
Chapter 7. Europe Pharmaceutical Sterility Testing Market by End-use
7.1 Europe Pharmaceutical Companies Market by Country
7.2 Europe Medical Device Companies Market by Country
7.3 Europe Compounding Pharmacies Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Pharmaceutical Sterility Testing Market by Test Type
8.1 Europe Bioburden Testing Market by Country
8.2 Europe Sterility Testing Market by Country
8.3 Europe Bacterial Endotoxin Testing Market by Country
Chapter 9. Europe Pharmaceutical Sterility Testing Market by Country
9.1 Germany Pharmaceutical Sterility Testing Market
9.1.1 Germany Pharmaceutical Sterility Testing Market by Type
9.1.2 Germany Pharmaceutical Sterility Testing Market by Product Type
9.1.3 Germany Pharmaceutical Sterility Testing Market by Sample
9.1.4 Germany Pharmaceutical Sterility Testing Market by End-use
9.1.5 Germany Pharmaceutical Sterility Testing Market by Test Type
9.2 UK Pharmaceutical Sterility Testing Market
9.2.1 UK Pharmaceutical Sterility Testing Market by Type
9.2.2 UK Pharmaceutical Sterility Testing Market by Product Type
9.2.3 UK Pharmaceutical Sterility Testing Market by Sample
9.2.4 UK Pharmaceutical Sterility Testing Market by End-use
9.2.5 UK Pharmaceutical Sterility Testing Market by Test Type
9.3 France Pharmaceutical Sterility Testing Market
9.3.1 France Pharmaceutical Sterility Testing Market by Type
9.3.2 France Pharmaceutical Sterility Testing Market by Product Type
9.3.3 France Pharmaceutical Sterility Testing Market by Sample
9.3.4 France Pharmaceutical Sterility Testing Market by End-use
9.3.5 France Pharmaceutical Sterility Testing Market by Test Type
9.4 Russia Pharmaceutical Sterility Testing Market
9.4.1 Russia Pharmaceutical Sterility Testing Market by Type
9.4.2 Russia Pharmaceutical Sterility Testing Market by Product Type
9.4.3 Russia Pharmaceutical Sterility Testing Market by Sample
9.4.4 Russia Pharmaceutical Sterility Testing Market by End-use
9.4.5 Russia Pharmaceutical Sterility Testing Market by Test Type
9.5 Spain Pharmaceutical Sterility Testing Market
9.5.1 Spain Pharmaceutical Sterility Testing Market by Type
9.5.2 Spain Pharmaceutical Sterility Testing Market by Product Type
9.5.3 Spain Pharmaceutical Sterility Testing Market by Sample
9.5.4 Spain Pharmaceutical Sterility Testing Market by End-use
9.5.5 Spain Pharmaceutical Sterility Testing Market by Test Type
9.6 Italy Pharmaceutical Sterility Testing Market
9.6.1 Italy Pharmaceutical Sterility Testing Market by Type
9.6.2 Italy Pharmaceutical Sterility Testing Market by Product Type
9.6.3 Italy Pharmaceutical Sterility Testing Market by Sample
9.6.4 Italy Pharmaceutical Sterility Testing Market by End-use
9.6.5 Italy Pharmaceutical Sterility Testing Market by Test Type
9.7 Rest of Europe Pharmaceutical Sterility Testing Market
9.7.1 Rest of Europe Pharmaceutical Sterility Testing Market by Type
9.7.2 Rest of Europe Pharmaceutical Sterility Testing Market by Product Type
9.7.3 Rest of Europe Pharmaceutical Sterility Testing Market by Sample
9.7.4 Rest of Europe Pharmaceutical Sterility Testing Market by End-use
9.7.5 Rest of Europe Pharmaceutical Sterility Testing Market by Test Type
Chapter 10. Company Profiles
10.1 Steris PLC
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 SWOT Analysis
10.2 Charles River Laboratories International, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Product Launches and Product Expansions:
10.2.5 SWOT Analysis
10.3 Thermo Fisher Scientific, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Geographical Expansions:
10.3.6 SWOT Analysis
10.4 SGS S.A.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 SWOT Analysis
10.5 Sartorius AG
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.6 SWOT Analysis
10.6 Sotera Health Company
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 SWOT Analysis
10.7 Pacific Biolabs, Inc.
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Laboratory Corporation of America Holdings
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 SWOT Analysis
10.9 Almac group
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Pace Analytical Services, LLC
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Acquisition and Mergers:
10.10.3 SWOT Analysis

Companies Mentioned

  • Steris PLC
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Sartorius AG
  • Sotera Health Company
  • Pacific Biolabs, Inc.
  • Laboratory Corporation of America Holdings
  • Almac Group
  • Pace Analytical Services, LLC

Methodology

Loading
LOADING...